Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002665)

HILIC POSITIVE ION MODE (Analysis AN004337)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13
ala-ala	ME630419	1.22	0.59	0.99	0.98	0.89	1.80	0.70	1.57	0.91	0.54	1.25	1.01	0.61
agmatine	ME630418	0.95	0.66	1.04	1.00	1.18	1.38	0.90	1.37	0.96	0.67	1.01	0.88	0.91
5-hydroxytryptophol	ME630410	0.91	1.55	0.90	0.91	1.53	0.72	0.95	0.78	0.73	0.81	0.88	0.90	1.07
ADMA	ME630417	0.81	1.15	0.89	0.86	1.40	1.06	1.08	0.87	0.99	0.88	0.81	0.88	1.03
5-methylcytidine	ME630411	0.85	1.16	0.95	0.94	1.11	0.98	1.08	0.89	1.09	0.94	0.98	0.86	1.07
5-methylcytosine	ME630412	1.20	0.71	1.02	1.02	0.63	1.43	0.75	1.22	0.72	1.32	0.79	1.49	0.92
1-methylnicotinamide	ME630404	0.88	1.12	0.97	0.97	0.94	0.92	1.06	0.99	1.04	1.05	1.00	1.03	1.05
21-deoxycortisol	ME630405	0.58	0.72	0.74	0.80	2.34	0.62	1.54	0.65	0.88	1.01	0.99	0.68	0.44
anserine	ME630423	0.55	1.22	0.77	0.79	2.30	0.61	1.04	0.65	1.04	0.58	0.92	0.54	1.13
arachidoyl ethanolamide	ME630424	1.01	0.77	0.84	0.85	0.66	1.89	0.82	1.70	0.83	0.85	1.11	1.07	0.73
2^-deoxyadenosine	ME630406	0.85	0.87	0.91	0.87	1.11	1.53	1.05	1.28	1.36	0.53	0.69	1.02	0.81
7-methylguanine	ME630413	0.92	1.01	0.91	0.90	1.11	1.11	1.14	0.99	1.05	1.03	0.91	1.00	0.83
alpha-glycerophosphocholine	ME630422	0.81	1.15	0.92	0.92	1.35	0.81	1.11	0.86	1.07	0.95	0.99	0.79	1.02
1-methylhistamine	ME630403	0.82	0.98	0.96	1.00	0.82	0.79	0.93	0.76	1.70	0.78	1.45	0.98	1.14
4-guanidinobutanoate	ME630409	0.86	1.03	0.88	0.91	1.43	0.84	0.99	0.84	0.86	0.91	0.86	1.06	1.25
adenosine	ME630416	1.01	1.13	0.96	0.95	1.17	1.21	0.90	0.99	0.78	1.01	0.83	0.99	0.94
arginine	ME630425	0.93	1.10	0.91	0.90	1.10	1.05	1.03	0.88	0.95	1.06	0.85	0.94	1.20
asparagine	ME630426	0.93	1.15	0.92	0.92	1.20	1.04	0.94	0.87	0.95	0.93	0.87	0.93	1.18
3-methylhistidine	ME630408	0.58	1.31	0.87	0.87	1.39	0.76	1.25	0.65	1.27	0.63	1.19	0.62	1.34
acisoga	ME630415	0.83	0.97	0.84	0.81	2.24	1.15	0.69	0.97	0.76	0.91	0.70	0.77	0.55
2^-deoxycytidine	ME630407	0.84	1.13	0.97	0.97	1.08	0.99	1.11	0.90	1.14	0.88	0.99	0.89	1.06
acetylcholine	ME630414	0.76	0.99	1.00	1.01	1.01	1.44	0.80	1.01	1.10	0.80	1.36	1.01	0.71
allantoin	ME630421	0.81	1.01	0.87	0.89	1.65	0.95	0.91	0.91	0.94	0.94	0.90	0.87	0.90
alanine	ME630420	0.84	1.16	0.93	0.94	1.14	0.98	1.05	0.78	1.03	0.93	0.96	0.95	1.19
1-methyladenosine	ME630401	0.87	1.06	0.98	1.00	1.12	1.01	1.06	1.02	0.97	0.99	0.88	0.96	1.01
1-methylguanosine	ME630402	0.88	1.11	0.90	0.91	1.30	1.01	1.13	0.84	1.03	1.04	0.87	0.94	0.81

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-DriftCorrection \| Timepoint:0 hour \| Sex:-
F4	Group:QC-Pooled \| Timepoint:0 hour \| Sex:-
F5	Group:QC-Reference \| Timepoint:0 hour \| Sex:-
F6	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F7	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F8	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F9	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F10	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F11	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F12	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F13	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix